AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6940466
Drug: High-dose induction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose induction chemotherapy (TAD) consisting of 6-thioguanine, cytarabine, and daunorubicin
Trial: 6940466
Drug: Intensive consolidation
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive consolidation chemotherapy followed by maintenance chemotherapy with immunotherapy
Trial: 6940466
Drug: Intensive consolidation
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive consolidation chemotherapy followed by maintenance chemotherapy without immunotherapy
Trial: 31775859
Drug: Intravaginal lactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravaginal lactic acid gel 5 ml once daily for 7 days
Trial: 31775859
Drug: Oral metronidazole
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral metronidazole tablets 400 mg twice daily for 7 days
Trial: 23246229
Drug: Berberine gelatin
RxNorm normalized name: berberine
DrugBank: Berberine (DB04115)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Berberine gelatin (5 mg/g) applied 4 times per day for 5 days
Trial: 21413865
Drug: Micronutrient supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronutrient supplement containing 12 vitamins and 9 minerals
Trial: 19684155
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) treatment for 12 months
Trial: 19684155
Drug: Etanercept treatment
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept treatment for nonresponders after 12 months of MTX
Trial: 15980646
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol termination
Trial: 15980646
Drug: Intra-amniotic injection
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-amniotic injection of prostaglandin termination
Trial: 6633618
Drug: Single-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose therapy with trimethoprim/sulfamethoxazole (43 courses)
Trial: 6633618
Drug: Single-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose therapy with tobramycin (23 courses)
Trial: 6633618
Drug: Therapy to
RxNorm normalized name: COOL THERAPY Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy to eradicate bacteriuria
Trial: 29952801
Drug: HeartMate II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HeartMate II pump position at implant
Trial: 28145818
Drug: Health education,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education, diet supervision and exercise supervision (twice a week)
Trial: 26054185
Drug: Dentifrices containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dentifrices containing 1.5% arginine, 1450 ppm fluoride as sodium monofluorophosphate (MFP), and an insoluble calcium compound (either dicalcium phosphate or calcium carbonate)
Trial: 23686738
Drug: Monthly ibandronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly ibandronate (150 mg)
Trial: 23686738
Drug: Weekly alendronate
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly alendronate (70 mg)
Trial: 17803060
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug (10 mg amlodipine tablet - Intervask)
Trial: 17803060
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug vs Reference drug
Trial: 10483844
Drug: Cognitive-behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behaviour therapy (CBT) with instructions to drop safety behaviours
Trial: 10483844
Drug: Standard cognitive-behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard cognitive-behaviour therapy (CBT)
Trial: 8630576
Drug: FK‐888 (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FK‐888 (2.5 mg)
Trial: 7049959
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate (75 mg/kg body weight)
Trial: 30707660
Drug: GEMOX (gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GEMOX (gemcitabine 1,000 mg/m2 on day 1 and oxaliplatin 85 mg/m2 on day 2 of a 2-week cycle for 12 cycles)
Trial: 12413183
Drug: Interviewer-administered questionnaires
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer-administered questionnaires (IAQ)
Trial: 9857596
Drug: 35% phosphoric
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35% phosphoric etching gel (pH 1) applied in the peri-implant sulcus
Trial: 9857596
Drug: Control therapy
RxNorm normalized name: Benzoyl Peroxide;Salicylic Acid;Vitamin E 8%; 2%; 5% Topical application Kit [INOVA 8/2 ACNE CONTROL THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control therapy with supra- and subgingival debridement using carbon fiber curettes and a rubber cup
Trial: 8730504
Drug: Combined low
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined low antigen diet and therapy
Trial: 26575180
Drug: Bupivacaine lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine lozenge
Trial: 23131885
Drug: N-acetylcysteine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (up to 2400 mg/d)
Trial: 12949359
Drug: High sterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High sterol margarine (1.5 g/d plant sterols + 0.5 g/d plant stanols)
Trial: 12949359
Drug: Low sterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low sterol margarine (1 g/d plant sterols + 1 g/d plant stanols)
Trial: 30819227
Drug: Venturi mask
RxNorm normalized name: MASK
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venturi mask oxygen therapy
Trial: 15944779
Drug: 5-FU continuous
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU continuous infusion (320 mg/m2/day) for 14 days followed by oral HCFU (300 mg/day) for one year
Trial: 15944779
Drug: 5-FU continuous
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-FU continuous infusion alone for 14 days
Trial: 10646729
Drug: Specific local
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific local nasal immunotherapy (LNIT) for 8 months
Trial: 10646729
Drug: Specific local
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific local nasal immunotherapy (LNIT) for allergy to mites
Trial: 10646729
Drug: Specific local
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific local nasal immunotherapy (LNIT)
Trial: 3729199
Drug: Caffeine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (250 mg, 30 minutes before breakfast)
Trial: 25683315
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (NS) injection
Trial: 16469442
Drug: Citalopram (CIT)
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram (CIT) 40 mg
Trial: 16469442
Drug: Melatonin (MT)
DrugBank: Melatonin (DB01065)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Melatonin (MT) 1 mg
Trial: 12680886
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (FP) 1000 microg day‐1 for 7 days
Trial: 12680886
Drug: Intravenous fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fluticasone propionate 1000 microg
Trial: 10846595
Drug: Genotype-guided treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genotype-guided treatment
Trial: 9106575
Drug: Pari LC
RxNorm normalized name: Pari LC Pediatric Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pari LC nebulizer system (300 mg tobramycin in 5 mL of 1/4 normal saline)
Trial: 9106575
Drug: Sidestream nebulizer
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sidestream nebulizer system (300 mg tobramycin in 5 mL of 1/4 normal saline)
Trial: 9106575
Drug: UltraNeb 99/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UltraNeb 99/100 nebulizer system (600 mg tobramycin in 30 mL of 1/2 normal saline)
Trial: 8229026
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of prednisone and azathioprine
Trial: 31104856
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of levo-pantoprazole
Trial: 31104856
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg of racemic pantoprazole
Trial: 22339386
Drug: Control (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (saline solution storage)
Trial: 9469347
Drug: Pamidronate 90
RxNorm normalized name: pamidronate 90 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate 90 mg intravenously administered as a 4-hour infusion monthly for 21 cycles
Trial: 8585642
Drug: Mupirocin ointment
RxNorm normalized name: Mupirocin Ointment
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin ointment alone
Trial: 8585642
Drug: Mupirocin ointment
RxNorm normalized name: Mupirocin Ointment
DrugBank: Mupirocin (DB00410)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mupirocin ointment plus chlorhexidine baths
Trial: 2096108
Drug: Heptaminol (626
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heptaminol (626 mg dose)
Trial: 582541
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of pimozide
Trial: 582541
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg of pimozide
Trial: 582541
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (3 mg and 8 mg)
Trial: 26711509
Drug: PfSPZ chemoprophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PfSPZ chemoprophylaxis vaccine (CVac) - 3× monthly immunizations with 7.5 × 10(4) PfSPZ
Trial: 26711509
Drug: PfSPZ chemoprophylaxis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PfSPZ chemoprophylaxis vaccine (CVac)
Trial: 19196113
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) - 12 J (4 J/cm²) applied intraorally and extraorally immediately after surgery
Trial: 15207420
Drug: Moderate intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate intensity exercise program (combination of aerobic/endurance activities, strength training, balance, and flexibility training)
Trial: 2687898
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil 20 mg/kg/day
Trial: 2687898
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil 40 mg/kg/day
Trial: 2687898
Drug: Cefaclor 30
RxNorm normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefaclor 30 mg/kg/day
Trial: 2687898
Drug: Cefetamet pivoxil
RxNorm normalized name: Cefetamet pivoxil
DrugBank: Cefetamet pivoxil (DB18915)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet pivoxil (both doses)
Trial: 27797396
Drug: Doxycycline 40
RxNorm normalized name: Doxycycline 40 mg ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 40 mg
Trial: 16385102
Drug: Combination analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination analgesic therapy; specific drugs and dosages not available.
Trial: 16385102
Drug: Individual component
RxNorm normalized name: thrombin
DrugBank: Thrombin (DB11300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individual component drugs; specific drugs and dosages not available.
Trial: 12626202
Drug: Corline Heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corline Heparin Surface (CHS) with standard level of heparin
Trial: 12626202
Drug: Corline Heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corline Heparin Surface (CHS) with high level of heparin
Trial: 12626202
Drug: Corline Heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corline Heparin Surface (CHS) with low level of heparin
Trial: 10520620
Drug: Pear juice
RxNorm normalized name: PEAR JUICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pear juice (120 mL)
Trial: 10520620
Drug: White grape
RxNorm normalized name: Herbal Essences White Grapefruit Shampoo
DrugBank: Wine grape (DB10634)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White grape juice (120 mL)
Trial: 7863649
Drug: Nurse-administered bed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-administered bed bath
Trial: 7863649
Drug: Nurse-administered interventions
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nurse-administered interventions (overall)
Trial: 7075123
Drug: Methadone (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (35 to 80 mg)
Trial: 7075123
Drug: Methadone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methadone (10 and 20 mg/day)
Trial: 31771598
Drug: Supplement containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplement containing caffeine, theanine and tyrosine (SUP)
Trial: 26228414
Drug: High-dose antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose antidepressant therapy
Trial: 26228414
Drug: Low-dose antidepressant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose antidepressant therapy
Trial: 26228414
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses (high, low, placebo)
Trial: 9489594
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg tamsulosin (as Omnic modified release capsules)
Trial: 9489594
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg terazosin (as Flotrin tablets)
Trial: 3254832
Drug: AWD 26‐06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AWD 26‐06 (50 mg and above)
Trial: 3254832
Drug: AWD 26‐06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AWD 26‐06 (100 mg and 150 mg)
Trial: 3254832
Drug: AWD 26‐06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AWD 26‐06 (150 mg)
Trial: 3254832
Drug: AWD 26‐06
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AWD 26‐06 (25 mg)
Trial: 26691357
Drug: Intralesional triamcinolone
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intralesional triamcinolone acetonide (10 mg/ml)
Trial: 26691357
Drug: Topical betamethasone
RxNorm normalized name: betamethasone Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical betamethasone valearate cream 0.1% twice daily
Trial: 23434331
Drug: Unpreserved timolol
RxNorm normalized name: timolol
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Unpreserved timolol 0.1% gel
Trial: 15259840
Drug: Fluoxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine plus cognitive-behavioural therapy (CBT+meds)
Trial: 15259840
Drug: Fluoxetine (meds
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (meds only)
Trial: 15259840
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (CBT+meds and meds only)
Trial: 14655830
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g L-tryptophan
Trial: 14655830
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g L-tryptophan
Trial: 14655830
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g L-tryptophan
Trial: 7951084
Drug: Salbutamol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (400 micrograms per day) + Beclocort (1 mg per day)
Trial: 7951084
Drug: Salbutamol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (400 micrograms per day) + Nedocromil (Tilade 8 mg per day)
Trial: 7951084
Drug: Salbutamol alone
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol alone or in combination with an anti-inflammatory agent
Trial: 2660997
Drug: Zinc chloride
RxNorm normalized name: Zinc Chloride
DrugBank: Zinc chloride (DB14533)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc chloride spray and magnesium hydroxide ointment applied twice daily for seven consecutive days
Trial: 28277603
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg subcutaneously every 6 months during the FREEDOM trial
Trial: 21493792
Drug: Intensive lipid
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive lipid therapy
Trial: 25007392
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg
Trial: 15274684
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of enalapril 10 mg and losartan 100 mg daily
Trial: 11016325
Drug: Eptifibatide (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eptifibatide (180 microg/kg bolus plus 2 microg/kg/min infusion)
Trial: 8872656
Drug: Carbohydrate (CHO)
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate (CHO) - 75 g glucose solution ingested 30 min before exercise
Trial: 8872656
Drug: Control (Con)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (Con) - sweet placebo solution ingested 30 min before exercise
Trial: 1618465
Drug: Sodium benzoate
RxNorm normalized name: Sodium Benzoate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium benzoate (5 gm twice daily)
Trial: 1618465
Drug: Lactulose (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactulose (dose adjusted for 2 or 3 semiformed stools/day)
Trial: 6662184
Drug: hydrochlorothiazide-amiloride combination
RxNorm normalized name: amiloride / hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hydrochlorothiazide-amiloride combination
Trial: 31965649
Drug: Multiple-dose cefazolin
RxNorm normalized name: Cefazolin
DrugBank: Cefazolin (DB01327)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple-dose cefazolin (3 days)
Trial: 28157791
Drug: Liposome bupivacaine
RxNorm normalized name: bupivacaine liposome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liposome bupivacaine (10 mL of liposome bupivacaine 133 mg) added to 5 mL of 0.25% bupivacaine HCl
Trial: 28157791
Drug: Standard bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard bupivacaine (15 mL of 0.25% bupivacaine HCl) alone
Trial: 24332192
Drug: Group exercise
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group exercise program (G)
Trial: 21823282
Drug: Acupuncture at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture at Tianshu (ST 25) and Dachangshu (BL 25), once daily for 4 weeks.
Trial: 21823282
Drug: Trimebutine Maleate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimebutine Maleate, 2 capsules, 3 times per day for 4 weeks.
Trial: 14709946
Drug: Sertraline (Zoloft)
RxNorm normalized name: sertraline Oral Solution [Zoloft]
DrugBank: Sertraline (DB01104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sertraline (Zoloft) 50 to 200 mg/d
Trial: 2724108
Drug: Xylocaine (lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylocaine (lidocaine hydrochloride) administered as a posterior tibial block
Trial: 2724108
Drug: Sensorcaine (bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensorcaine (bupivacaine hydrochloride) administered as a posterior tibial block
Trial: 26338094
Drug: Patisiran 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patisiran 0.3 mg/kg every 3 weeks (Q3W)
Trial: 31843791
Drug: PPV alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPV alone (conventional treatment)
Trial: 16454979
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus clopidogrel (loading dose of 300 mg aspirin and 300 mg clopidogrel, then 100 mg aspirin and 75 mg clopidogrel per day)